
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA093393(RETNLB Antibody) at dilution 1/20, on the right is treated with fusion protein. (Original magnification: x200)
RETNLB Antibody
CSB-PA093393
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetRETNLB
Overview
- SupplierCusabio
- Product NameRETNLB Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID84666
- Target nameRETNLB
- Target descriptionresistin like beta
- Target synonymsC/EBP-epsilon regulated myeloid-specific secreted cysteine-rich protein precursor 2; colon and small intestine-specific cysteine-rich protein; colon carcinoma-related gene protein; cysteine-rich secreted A12-alpha-like protein 1; cysteine-rich secreted protein A12-alpha-like 1; cysteine-rich secreted protein FIZZ2; FIZZ1; FIZZ2; found in inflammatory zone 1; HXCP2; RELMb; RELMbeta; RELM-beta; resistin-like beta; XCP2
- HostRabbit
- IsotypeIgG
- Protein IDQ9BQ08
- Protein NameResistin-like beta
- Scientific DescriptionResistin-like beta is a protein that in humans is encoded by the RETNLB gene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC41116161